Close Menu

MRSA

The company attributed the increase in revenue to a $700,000 increase in product sales, particularly its rapid pathogen ID molecular diagnostic.

Researchers examined virulence, resistance, and transmission patterns in genome sequence data for more than 300 invasive Staphylococcus aureus isolates from Europe.

The upgraded test includes new gene targets for methicillin resistance, and provides room-temperature storage and validation on multiple swab types.

The approach allows more rapid detection of resistant strains as well as detection of certain populations for which good clinical assays don't currently exist.

The technology is being used to analyze pathogen samples in a clinical study examining methods to combat recurrent drug-resistant Staph infections.

Wells Fargo downgraded Cepheid from Outperform to Market Perform, citing the firm's "credibility and visibility" following a revised 2017 outlook.

If approved, the multiplex Staph panel will grow the firm's menu of assays on its molecular platform to three.

Trace Their Path

Genome sequencing is a new tool in the fight against drug-resistant bacteria, writes Lara Marks at The Conversation.

GeneWeave's rule-in antibiotic susceptibility testing works where PCR doesn't and offers Roche the possibility of reshaping the microbiology laboratory.

In Genome Biology this week: MRSA genetic diversity, genome features linked to bee sociality, and more.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.